NCT05528653View on ClinicalTrials.gov

"Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: e-PrEP"

PHASE4CompletedINTERVENTIONAL

Enrollment

75

Participants

Timeline

Start Date

July 19, 2022

Primary Completion Date

July 31, 2024

Study Completion Date

March 21, 2025

Conditions

HIV Prevention

Interventions

DRUG

Descovy

HIV infection pre-exposure prophylaxis

Trial Locations (3)

53203

Viventh Health, Milwaukee

63103

Vivent Health, St Louis

80245

Vivent Health, Denver

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Gilead Sciences

INDUSTRY

lead

Vivent Health

OTHER

NCT05528653 - "Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: e-PrEP" | Biotech Hunter | Biotech Hunter